BioCentury
ARTICLE | Finance

Jumping IT ship

Why TVM is shifting away from IT to focus on life sciences

November 11, 2013 8:00 AM UTC

TVM Capital is sharpening its focus as it targets a final close of $200 million in 1Q14 for its seventh life sciences venture fund.

Last week, the firm said it will stop making investments in IT. Starting next year, it will focus on venture investments in biopharma and medtech in Western Europe and North America...